Career history of Eric Pottier
Former positions of Eric Pottier
Companies | Position | Start | End |
---|---|---|---|
TXCELL | Chief Operating Officer | 21/01/2013 | 31/12/2013 |
Corporate Officer/Principal | 31/12/2013 | 29/02/2016 | |
Eurand SpA
Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Corporate Officer/Principal | - | - |
Training of Eric Pottier
L'Université d'Angers | Doctorate Degree |
Statistics
International
France | 3 |
Italy | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Eurand SpA
Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy. | Health Technology |
- Stock Market
- Insiders
- Eric Pottier
- Experience